Randomized Clinical Trial to Increase Physical Activity After a a Hypertensive Pregnancy
STEPUP
A Randomized, Clinical Trial Evaluating Methods to Increase Physical Activity After a Pregnancy Complicated by a Hypertensive Disorder
1 other identifier
interventional
128
1 country
1
Brief Summary
STEPUP is a 12-week randomized clinical trial among 126 postpartum women with pregnancies complicated by hypertensive disorders. Participants will be randomized to a control arm and receive a Fitbit or an intervention arm. The intervention arm will receive a Fitbit and set a step count goal, receive daily feedback via text about whether they reached their goal, and will be placed in virtual teams with other participants where they can win points for their team if they meet their daily goals. The main study outcomes will be increase in mean step count and change in psychosocial survey measures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 7, 2019
CompletedFirst Posted
Study publicly available on registry
October 8, 2019
CompletedStudy Start
First participant enrolled
October 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 18, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 5, 2020
CompletedDecember 14, 2020
December 1, 2020
8 months
October 7, 2019
December 11, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Change in mean daily steps
Change in mean daily step count from the baseline period (weeks 1-2) to the intervention period (weeks 3-14)
weeks 3 to 14 of the intervention
Secondary Outcomes (12)
Proportion of participant-days that step goals are achieved
weeks 3 to 14 of the intervention
Mean daily steps during the 12-week intervention period adjusted for baseline step count
12-week intervention period
Change in perceived social support scale
weeks 3 to 14 of the intervention
Change in Edinburgh postnatal depression scale (EPDS)
weeks 3 to 14 of the intervention
Change in Systolic blood pressure
weeks 3 to 14 of the intervention
- +7 more secondary outcomes
Study Arms (2)
Control
NO INTERVENTIONIndividual participants will use a wearable device to monitor daily step counts, set a step goal, and receive automated daily feedback on step goal attainment.
Social incentives-based program
EXPERIMENTALIndividual participants will use a wearable device to monitor daily step counts, set a step goal, and receive automated daily feedback on step goal attainment. Participants will be placed on a team of 3 randomly assigned participants and receive the social incentives intervention.
Interventions
Individual participants will use a wearable device to monitor daily step counts, set a step goal, and receive automated daily feedback on step goal attainment. Participants will be placed on a team of 3 randomly assigned participants and receive the social incentives intervention.
Eligibility Criteria
You may qualify if:
- Delivered a live baby at HUP or PAH within 4.0-12.6 weeks prior to study enrollment;
- Diagnosis of chronic hypertension, gestational hypertension, or preeclampsia during most recent pregnancy;
- Participating in Heart Safe Motherhood (HSM) program;
- Ability to read and provide informed consent to participate in the study;
- Has smartphone and email address
You may not qualify if:
- Does not speak English
- Answers yes to any of the following questions:
- Are you currently participating in any other physical activity studies?
- Do you have any medical conditions or other reasons why you could not participate in a 12-week physical activity program?
- Participants will be excluded after completing the baseline period if their baseline step count is too high (greater than or equal to 10,000 steps per day).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 7, 2019
First Posted
October 8, 2019
Study Start
October 10, 2019
Primary Completion
June 18, 2020
Study Completion
October 5, 2020
Last Updated
December 14, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share